In vivo optical imaging of the viable epidermis around the nailfold capillaries for the assessment of heart failure severity in humans

J Biophotonics. 2018 Sep;11(9):e201800066. doi: 10.1002/jbio.201800066. Epub 2018 Jun 19.

Abstract

Heart failure (HF) is among the socially significant diseases, involving over 2% of the adult population in the developed countries. Diagnostics of the HF severity remains complicated due to the absence of specific symptoms and objective criteria. Here, we present an indicator of the HF severity based on the imaging of tissue parameters around the nailfold capillaries. High resolution nailfold video capillaroscopy was performed to determine the perivascular zone (PZ) size around nailfold capillaries, and 2-photon tomography with fluorescence lifetime imaging was used to investigate PZ composition. We found that the size of PZ around the nailfold capillaries strongly correlates with HF severity. Further investigations using 2-photon tomography demonstrated that PZ corresponds to the border of viable epidermis and it was suggested that the PZ size variations were due to the different amounts of interstitial fluid that potentially further translates in clinically significant oedema. The obtained results allow for the development of a quantitative indicator of oedematous syndrome, which can be used in various applications to monitor the dynamics of interstitial fluid retention. We therefore suggest PZ size measured with nailfold video capillaroscopy as a novel quantitative sensitive non-invasive marker of HF severity.

Keywords: 2-photon tomography; edematous syndrome; epidermis; in vivo diagnostics; interstitial fluid; nailfold capillaroscopy; papillary dermis; rete ridges.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Case-Control Studies
  • Epidermis / diagnostic imaging*
  • Epidermis / physiology
  • Female
  • Heart Failure / diagnostic imaging*
  • Humans
  • Male
  • Microscopic Angioscopy*
  • Middle Aged
  • Optical Imaging*
  • Photons
  • Tissue Survival*